List of bibliographic references
Number of relevant bibliographic references: 10.
List of associated KwdEn.i
Nombre de documents | Descripteur |
6 | Animals |
5 | Humans |
4 | Mice |
3 | Female |
3 | Mice, Inbred C57BL |
2 | Anthracyclines (therapeutic use) |
2 | Cell Line, Tumor |
2 | Flow Cytometry |
2 | Killer Cells, Natural (immunology) |
2 | Lymphocyte Activation |
2 | Neoplasms, Experimental (immunology) |
2 | Signal Transduction |
2 | Transforming Growth Factor beta (immunology) |
1 | Accessory cell |
1 | Adaptor Proteins, Vesicular Transport (metabolism) |
1 | Adolescent |
1 | Adult |
1 | Aged |
1 | Aged, 80 and over |
1 | Anthracyclines (pharmacology) |
1 | Antibodies, Monoclonal (pharmacology) |
1 | Antibodies, Monoclonal (therapeutic use) |
1 | Antigen Presentation |
1 | Antigen presenting cell |
1 | Antigen-Presenting Cells (drug effects) |
1 | Antigen-Presenting Cells (immunology) |
1 | Antigens, Neoplasm (metabolism) |
1 | Antineoplastic Agents (therapeutic use) |
1 | Breast Neoplasms (drug therapy) |
1 | Breast Neoplasms (genetics) |
1 | Breast Neoplasms (immunology) |
1 | Breast Neoplasms (pathology) |
1 | CC chemokine |
1 | CC-chemokine ligand 2 |
1 | CCR2 chemokine receptor |
1 | CD4-Positive T-Lymphocytes (immunology) |
1 | CD4-Positive T-Lymphocytes (metabolism) |
1 | CTLA-4 Antigen (immunology) |
1 | CTLA-4 Antigen (metabolism) |
1 | Case-Control Studies |
1 | Cellular Reprogramming (immunology) |
1 | Chemokine CCL2 (genetics) |
1 | Chemokine CCL2 (metabolism) |
1 | Chemokine CXCL10 (metabolism) |
1 | Chemokine receptor |
1 | Chemotherapy |
1 | Cohort Studies |
1 | Dendritic Cells (cytology) |
1 | Disease Models, Animal |
1 | Doxorubicin (pharmacology) |
1 | Doxorubicin (therapeutic use) |
1 | Enzyme-Linked Immunosorbent Assay |
1 | Fibrosarcoma (immunology) |
1 | Gastrointestinal Neoplasms (immunology) |
1 | Gastrointestinal Stromal Tumors (immunology) |
1 | Gene Expression Profiling |
1 | Gene Expression Regulation, Neoplastic (drug effects) |
1 | Immunity, Cellular |
1 | Immunity, Innate (immunology) |
1 | Immunocompetence (drug effects) |
1 | Immunotherapy |
1 | Immunotherapy (methods) |
1 | Interferon Type I (biosynthesis) |
1 | Interferon Type I (metabolism) |
1 | Interleukin-15 (immunology) |
1 | Interleukin-2 Receptor alpha Subunit (blood) |
1 | Interleukin-2 Receptor alpha Subunit (immunology) |
1 | Killer Cells, Natural (cytology) |
1 | Killer Cells, Natural (pathology) |
1 | Lymph Node Excision |
1 | Lymphocytes (cytology) |
1 | Lymphocytes (immunology) |
1 | Male |
1 | Malignant tumor |
1 | Melanoma (mortality) |
1 | Melanoma (pathology) |
1 | Melanoma (therapy) |
1 | Mice, Knockout |
1 | Mice, Transgenic |
1 | Microscopy, Fluorescence |
1 | Middle Aged |
1 | Monocyte chemoattractant protein 1 |
1 | Myxovirus Resistance Proteins (metabolism) |
1 | Neoadjuvant Therapy |
1 | Neoplasm Metastasis |
1 | Neoplasm Transplantation |
1 | Neoplasms (drug therapy) |
1 | Neoplasms (immunology) |
1 | Neoplasms (therapy) |
1 | Neoplasms, Experimental (genetics) |
1 | Oligonucleotide Array Sequence Analysis |
1 | RNA (metabolism) |
1 | RNA, Messenger (genetics) |
1 | RNA, Messenger (metabolism) |
1 | Receptor, Interferon alpha-beta (metabolism) |
1 | Receptors, CCR2 (metabolism) |
1 | Receptors, Interleukin-2 (genetics) |
1 | Receptors, Interleukin-2 (immunology) |
1 | Receptors, Interleukin-2 (metabolism) |
1 | Receptors, Pattern Recognition (metabolism) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Mark J. Smyth"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Mark J. Smyth" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Mark J. Smyth
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |